piwi相互作用rna (pirna)在心血管疾病中的调节作用

IF 4.1 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Pushkar Shivam, Destiny Ball, Ayorinde Cooley, Inmar Osi, Kayla J Rayford, Said B Gonzalez, Alayjha D Edwards, Antonisha R McIntosh, Jessica Devaughn, Jada P Pugh-Brown, Smita Misra, Annet Kirabo, Aramandla Ramesh, Merry L Lindsey, Amos M Sakwe, Amadou Gaye, Antentor Hinton, Pamela M Martin, Pius N Nde
{"title":"piwi相互作用rna (pirna)在心血管疾病中的调节作用","authors":"Pushkar Shivam, Destiny Ball, Ayorinde Cooley, Inmar Osi, Kayla J Rayford, Said B Gonzalez, Alayjha D Edwards, Antonisha R McIntosh, Jessica Devaughn, Jada P Pugh-Brown, Smita Misra, Annet Kirabo, Aramandla Ramesh, Merry L Lindsey, Amos M Sakwe, Amadou Gaye, Antentor Hinton, Pamela M Martin, Pius N Nde","doi":"10.1152/ajpheart.00833.2024","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiovascular disease remains the number one cause of death worldwide. Across the spectrum of cardiovascular pathologies, all are accompanied by changes in gene expression profiles spanning a variety of cellular components of the myocardium. Alterations in gene expression are regulated by small noncoding RNAs (sncRNAs), with P-element-induced WImpy testis (PIWI)-interacting RNAs (piRNAs) being the most abundant of the sncRNAs in the human genome. Composed of 21-35 nucleotides in length with a protective methyl group at the 3' end, piRNAs complex with highly conserved RNA-binding proteins termed PIWI proteins to recruit enzymes used for histone, DNA, RNA, and protein modifications. Thus, specific piRNA expression patterns can be exploited for early clinical diagnosis of cardiovascular disease and the development of novel RNA therapeutics that may improve cardiac health outcomes. This review summarizes the latest progress made on understanding how piRNAs regulate cardiovascular health and disease progression, including a discussion of their potential in the development of biomarkers and therapeutics.</p>","PeriodicalId":7692,"journal":{"name":"American journal of physiology. Heart and circulatory physiology","volume":" ","pages":"H991-H1004"},"PeriodicalIF":4.1000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Regulatory roles of PIWI-interacting RNAs in cardiovascular disease.\",\"authors\":\"Pushkar Shivam, Destiny Ball, Ayorinde Cooley, Inmar Osi, Kayla J Rayford, Said B Gonzalez, Alayjha D Edwards, Antonisha R McIntosh, Jessica Devaughn, Jada P Pugh-Brown, Smita Misra, Annet Kirabo, Aramandla Ramesh, Merry L Lindsey, Amos M Sakwe, Amadou Gaye, Antentor Hinton, Pamela M Martin, Pius N Nde\",\"doi\":\"10.1152/ajpheart.00833.2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cardiovascular disease remains the number one cause of death worldwide. Across the spectrum of cardiovascular pathologies, all are accompanied by changes in gene expression profiles spanning a variety of cellular components of the myocardium. Alterations in gene expression are regulated by small noncoding RNAs (sncRNAs), with P-element-induced WImpy testis (PIWI)-interacting RNAs (piRNAs) being the most abundant of the sncRNAs in the human genome. Composed of 21-35 nucleotides in length with a protective methyl group at the 3' end, piRNAs complex with highly conserved RNA-binding proteins termed PIWI proteins to recruit enzymes used for histone, DNA, RNA, and protein modifications. Thus, specific piRNA expression patterns can be exploited for early clinical diagnosis of cardiovascular disease and the development of novel RNA therapeutics that may improve cardiac health outcomes. This review summarizes the latest progress made on understanding how piRNAs regulate cardiovascular health and disease progression, including a discussion of their potential in the development of biomarkers and therapeutics.</p>\",\"PeriodicalId\":7692,\"journal\":{\"name\":\"American journal of physiology. Heart and circulatory physiology\",\"volume\":\" \",\"pages\":\"H991-H1004\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of physiology. Heart and circulatory physiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1152/ajpheart.00833.2024\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of physiology. Heart and circulatory physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1152/ajpheart.00833.2024","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

心血管疾病仍然是全球头号死因。在各种心血管病变中,都伴随着基因表达谱的变化,涉及心肌的各种细胞成分。基因表达的改变受小型非编码 RNA(sncRNA)的调控,而 Piwi-interacting RNA(piRNA)是人类基因组中最丰富的 sncRNA。piRNA 长度为 21 - 35 个核苷酸,3'端有一个保护性甲基,与高度保守的 RNA 结合蛋白(称为 PIWI 蛋白)复合,以招募用于组蛋白、DNA、RNA 和蛋白质修饰的酶。因此,特定 piRNA 的表达模式可用于心血管疾病的早期临床诊断和新型 RNA 治疗药物的开发,从而改善心脏健康状况。这篇综述总结了在了解 piRNA 如何调控心血管健康和疾病进展方面取得的最新进展,包括讨论它们在开发生物标记物和疗法方面的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Regulatory roles of PIWI-interacting RNAs in cardiovascular disease.

Cardiovascular disease remains the number one cause of death worldwide. Across the spectrum of cardiovascular pathologies, all are accompanied by changes in gene expression profiles spanning a variety of cellular components of the myocardium. Alterations in gene expression are regulated by small noncoding RNAs (sncRNAs), with P-element-induced WImpy testis (PIWI)-interacting RNAs (piRNAs) being the most abundant of the sncRNAs in the human genome. Composed of 21-35 nucleotides in length with a protective methyl group at the 3' end, piRNAs complex with highly conserved RNA-binding proteins termed PIWI proteins to recruit enzymes used for histone, DNA, RNA, and protein modifications. Thus, specific piRNA expression patterns can be exploited for early clinical diagnosis of cardiovascular disease and the development of novel RNA therapeutics that may improve cardiac health outcomes. This review summarizes the latest progress made on understanding how piRNAs regulate cardiovascular health and disease progression, including a discussion of their potential in the development of biomarkers and therapeutics.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.60
自引率
10.40%
发文量
202
审稿时长
2-4 weeks
期刊介绍: The American Journal of Physiology-Heart and Circulatory Physiology publishes original investigations, reviews and perspectives on the physiology of the heart, vasculature, and lymphatics. These articles include experimental and theoretical studies of cardiovascular function at all levels of organization ranging from the intact and integrative animal and organ function to the cellular, subcellular, and molecular levels. The journal embraces new descriptions of these functions and their control systems, as well as their basis in biochemistry, biophysics, genetics, and cell biology. Preference is given to research that provides significant new mechanistic physiological insights that determine the performance of the normal and abnormal heart and circulation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信